Clinical practice: Adult attention deficit-hyperactivity disorder.
Volkow, Nora D; Swanson, James M.
N Engl J Med
; 369(20): 1935-44, 2013 Nov 14.
Artigo em Inglês | MEDLINE | ID: mdl-24224626
Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.
Current issues around the pharmacotherapy of ADHD in children and adults.
The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.
Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence.
Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis.
Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate.
A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD).
Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD.
Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners.
Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants.